Patients with an SCN1A mutation accounted for the largest proportion, 17% (8/46), of which seven patients were diagnosed as Dravet syndrome and one patient was diagnosed as MMPSI. This evidence concerns the gene SCN1A and malignant migrating partial seizures of infancy.